Bjorn Frendeus Email

Chief Scientific Officer . Bioinvent International

Current Roles

Employees:
159
Revenue:
$24.6M
About
BioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapies, with four programs in clinical development. The Company's validated, proprietary F.I.R.S.Tâ„¢ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.
Bioinvent International Address
Sölvegatan 41
Lund, null
Bioinvent International Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.